NG-aEpCAM

N/A

Report date: 2026/03/19 16:57:28

Base Information

Drug NameNG-aEpCAM
Drug Alias Nameanti-CD3/anti-EpCam bispecific T-cell engager (PsiOxus Therapeutics)EnAd-Ep-Tactransgene-modified enadenotucirev producing anti-CD3/anti-EpCAM bispecific T-cell engager (PsiOxus)NG-611
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Oncolytic virusBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsEpithelial cell adhesion molecule modulators
TargetsEpithelial cell adhesion moleculeT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkamis Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAkamis Bio Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A